| Acute Coronary Syndrome |
1 |
1 |
| Coronary Artery Disease (CAD) |
0 |
0.91 |
| Heart |
0 |
0.85 |
| Artery |
0 |
0.8 |
| Atherosclerosis |
0 |
0.41 |
| Gout |
0 |
0.37 |
| Myocardial Infarction (MI) |
0 |
0.9 |
| Grant |
0 |
0.32 |
| Infarction |
0 |
0.32 |
| Lipids Management |
0 |
0.25 |
| Cerebrovascular Accident |
0 |
0.21 |
| Health Care Reform |
0 |
0.21 |
| Meta-Analysis |
0 |
0.21 |
| Peripheral Artery Disease |
0 |
0.21 |
| Outpatient Clinic |
0 |
0.18 |
| Thromboembolism |
0 |
0.17 |
| Liver Disease |
0 |
0.15 |
| COVID-19 |
0 |
0.12 |
| Genomic Medicine |
0 |
0.12 |
| Anti-inflammatory Agents |
0 |
0.88 |
| Aspirin |
0 |
0.11 |
| Board Certification |
0 |
0.11 |
| Canada |
0 |
0.11 |
| Impairment |
0 |
0.11 |
| Ischemia |
0 |
0.11 |
| Ischemic Stroke |
0 |
0.75 |
| Office Visits |
0 |
0.11 |
| Patient History |
0 |
0.11 |
| Pharmacogenomics |
0 |
0.11 |
| Statins |
0 |
0.11 |